Peter de Boer

9.6k citations

209 papers · 7.2k indexed · h-index 43

Impact in

Biological Psychiatry top 0.2%
- Tryptophan and brain disorders
Behavioral Neuroscience top 1%
- Stress Responses and Cortisol

Papers in

Biological Psychiatry 20
- Tryptophan and brain disorders 20
Behavioral Neuroscience 12

Co-authors: E. J. Dorhout Mees Hein A. Koomans Ton J. Rabelink G. G. Geyskes Wayne C. Drevets Branko Braam Jan C. Roos Ronald J. Hené
Journals: Kidney International (13 papers)European Journal of Pharmacology (10 papers)Hypertension (10 papers)Journal of Psychopharmacology (10 papers)The Nephron journals/Nephron journals (6 papers)
Partner nations: Netherlands Belgium United States

In The Last Decade

Peter de Boer

204 papers receiving 6.9k citations

Peers

Countries citing papers authored by Peter de Boer

Since Specialization

Citations

This map shows the geographic impact of Peter de Boer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter de Boer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter de Boer more than expected).

Fields of papers citing papers by Peter de Boer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter de Boer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter de Boer. The network helps show where Peter de Boer may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Peter de Boer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter de Boer Line = papers co-authored together Peter de Boer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Characterization of the central nervous system penetrant and selective purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder Translational Psychiatry ·G.G. Goodchild, Peter de Boer, Peter van der Ark, Heike Beneš, Joop van Gerven, Marc Ceusters, Luc Van Nueten, Wayne C. Drevets, Joseph B. Schuyler, Michael Browning, Gabriël E. Jacobs	2023	36
2	Characterisation of the pharmacodynamic effects of the P2X7 receptor antagonist JNJ-54175446 using an oral dexamphetamine challenge model in healthy males in a randomised, double-blind, placebo-controlled, multiple ascending dose trial Journal of Psychopharmacology ·G.G. Goodchild, Jasper van der Aart, Gabriël E. Jacobs, Marieke de Kam, Wayne C. Drevets, Luc Van Nueten, Aaron Kakazu, Pieter Siebenga, Rob Zuiker, Paulien Ravenstijn, Maarten Timmers, Joop van Gerven, Peter de Boer	2020	44
3	A randomized Phase 2 study to evaluate the orexin-2 receptor antagonist seltorexant in individuals with insomnia without psychiatric comorbidity Journal of Psychopharmacology ·Peter de Boer, Wayne C. Drevets, Hany Rofael, Peter van der Ark, Justine Kent, Iva Kezic, Silvia Parapatics, Georg Dorffner, Joop van Gerven, Heike Beneš, Christian Keicher, Holger Jahn, David Seiden, R. Luthringer	2018	45
4	Multiple daytime administration of the selective orexin-2 receptor antagonist JNJ-42847922 induces somnolence in healthy subjects without residual central effects Journal of Psychopharmacology ·Peter van der Ark, Georg Golor, Luc Van Nueten, Partha Nandy, Peter de Boer	2018	16
5	Differential Effects of Inflammatory and Psychosocial Stress on Mood, Hypothalamic-Pituitary-Adrenal Axis, and Inflammation in Remitted Depression Neuropsychobiology ·Willy Marcell Ndayitwayeko, Peter de Boer, Glenn Dumont, Filip Van Den Eede, Erik Fransén, Stephan Claes, Manuel Morrens, Bernard Sabbe	2016	17
6	In vivoelectric conductivity of cervical cancer patients based on $B_{1}^{+}$ maps at 3T MRI Physics in Medicine and Biology ·Duke Jung, Peter de Boer, Astrid L.H.M.W. van Lier, Rob Remis, Lukas J.A. Stalpers, G.H. Westerveld, Aart J. Nederveen, Cornelis A. T. van den Berg, Johannes Crezee	2016	48
7	Pharmacokinetic and pharmacodynamic characterisation of JNJ-40411813, a positive allosteric modulator of mGluR2, in two randomised, double-blind phase-I studies Journal of Psychopharmacology ·Sandra C. Crux, Ion Anghelescu, Iva Kezic, Vikash Sinha, Eef Hoeben, Luc Van Nueten, Heidi De Smedt, Peter de Boer	2015	42
8	Role of MRI in detecting involvement of the uterine internal os in uterine cervical cancer: Systematic review of diagnostic test accuracy European Journal of Radiology ·Peter de Boer, Judit A. Adam, Marrije R. Buist, Marc J. van de Vijver, C. Rasch, Jaap Stoker, Shandra Bipat, Lukas J.A. Stalpers	2013	34
9	Ketamine effects on brain function — Simultaneous fMRI/EEG during a visual oddball task NeuroImage ·Francesco Musso, Jürgen Brinkmeyer, Daniel Ecker, 博司古田, Vincent Ozoaniamalu, Tracy Warbrick, Hans‐Jörg Wittsack, Andreas Saleh, Lina Žigelytė, Peter de Boer, Georg Winterer	2011	66
10	Urinary Aldosterone to Creatinine Ratio in Cats before and after Suppression with Salt or Fludrocortisone Acetate Journal of Veterinary Internal Medicine ·S.C. Djajadiningrat‐Laanen, Sara Galac, A Bersky, Nitish Munjal, Peter de Boer, H.S. Kooistra	2008	19
11	Aldosterone-to-Renin and Cortisol-to-Adrenocorticotropic Hormone Ratios in Healthy Dogs and Dogs with Primary Hypoadrenocorticism Journal of Veterinary Internal Medicine ·Shahram Javadi, Sara Galac, Peter de Boer, Joris H. Robben, Erik Teske, H.S. Kooistra	2006	42
12	Hypercholesterolemia in Rats Induces Podocyte Stress and Decreases Renal Cortical Nitric Oxide Synthesis via an Angiotensin II Type 1 Receptor–Sensitive Mechanism Journal of the American Society of Nephrology ·Murugaiah Nadesan, Olivier Féron, Roel Goldschmeding, Rosaleen Davies, Nosratola D. Vaziri, Peter de Boer, Jean‐Luc Balligand, Hein A. Koomans, Jaap A. Joles	2004	22
13	Inhibition of p38 mitogen-activated protein kinase: Dose-dependent suppression of leukocyte and endothelial response after endotoxin challenge in humans* Critical Care Medicine ·J. W. Fijen, Jaap E. Tulleken, Anneke C. Muller Kobold, Peter de Boer, Tjip S. van der Werf, Jack J. M. Ligtenberg, Rob Spanjersberg, Jan G. Zijlstra	2002	30
14	Aldosteronoma in a dog with polyuria as the leading symptom Domestic Animal Endocrinology ·A. Rijnberk, H.S. Kooistra, Renata Amborska, Jan A. Mol, George Voorhout, F.J. van Sluijs, Jooske IJzer, T.S.G.A.M. van den Ingh, Peter de Boer, Walther H. Boer	2001	24
15	Blood volume, colloid osmotic pressure and F-cell ratio in children with the nephrotic syndrome Kidney International ·Junhang Zhang, Ebru Mazlum Güven, Peter de Boer, В. О. Трунов, H. A. Koomans, J.A. Joles	1996	34
16	A novel approach for studying septo-hippocampal cholinergic neurons in freely moving rats: a microdialysis study with dual-probe design Brain Research ·J. Bornmüller, Peter de Boer, Mariusz Plich, Ben H.C. Westerink	1994	30
17	In vitro and in vivo acetylcholine release from rat striatum as a functional paradigm of signal transduction via a D-2 dopamine receptor Neurochemistry International ·J.C. Stoof, Benjamin Drukarch, Peter de Boer, 藍斗藤田	1992	7
18	Changes in Intrarenal Uric Acid Handling during Chronic Spironolactone Treatment in Patients with Essential Hypertension The Nephron journals/Nephron journals ·Jan C. Roos, Peter de Boer, David A. Alhadeff, Rossana Quiñones	1982	7
19	Workshop on chromosomal aspects of male sterility in mammals, summary and synthesis Reproduction ·Peter de Boer, A.G. Searle	1980	18
20	"Outpatient hyperkalemia" syndrome in renal and hypertensive patients with suppressed aldosterone production. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·金宝玉, Peter de Boer, Jessa Marie J. Millanar-Marfa, M. Torres Lacruz	1979	3

About Peter de Boer

Peter de Boer is a scholar working on Biological Psychiatry, Behavioral Neuroscience, Nephrology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism, having authored 209 papers that have together received 7.2k indexed citations. Recurring topics across this work include Hormonal Regulation and Hypertension (27 papers), Blood Pressure and Hypertension Studies (27 papers), Tryptophan and brain disorders (20 papers), Electrolyte and hormonal disorders (18 papers), Neurotransmitter Receptor Influence on Behavior (18 papers), Renin-Angiotensin System Studies (18 papers), Neuroscience and Neuropharmacology Research (15 papers) and Receptor Mechanisms and Signaling (14 papers). The work is most often cited by research in Biological Psychiatry (934 citations), Behavioral Neuroscience (511 citations), Nephrology (714 citations), Cellular and Molecular Neuroscience (1.2k citations) and Endocrine and Autonomic Systems (409 citations). Peter de Boer has collaborated with scholars based in Netherlands, Belgium and United States. Frequent co-authors include E. J. Dorhout Mees, Hein A. Koomans, Ton J. Rabelink, G. G. Geyskes, Wayne C. Drevets, Branko Braam, Jan C. Roos, Ronald J. Hené, Ben H.C. Westerink and H. A. Koomans. Their work appears in journals such as Kidney International, European Journal of Pharmacology, Hypertension, Journal of Psychopharmacology and The Nephron journals/Nephron journals.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact